These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37930615)

  • 41. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.
    Woo PC; Lau SK; Wong BH; Tsoi HW; Fung AM; Kao RY; Chan KH; Peiris JS; Yuen KY
    J Clin Microbiol; 2005 Jul; 43(7):3054-8. PubMed ID: 16000415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of monoclonal antibody against SARS coronavirus nucleocapsid antigen and development of an antigen capture ELISA.
    He Q; Du Q; Lau S; Manopo I; Lu L; Chan SW; Fenner BJ; Kwang J
    J Virol Methods; 2005 Jul; 127(1):46-53. PubMed ID: 15893565
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role and diagnostic accuracy of serology for COVID-19.
    Kundu D; Gautam P; Dayanand D; Gunasekaran K; Manesh A; Sebastian M; Abhilash KPP; Zachariah A; George T; Sathyendra S; Hansdak SG; Abraham OC; Iyadurai R; Thangakunam B; Gupta R; Karthik R; Moorthy M; Varghese GM
    BMC Infect Dis; 2022 Apr; 22(1):390. PubMed ID: 35439957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of lateral flow and ELISA techniques for detecting IgG and IgM antibodies in COVID-19 cases in Türkiye.
    Arikan A; Doluca O; Akhan S; Sanlidag T; Sayan M
    East Mediterr Health J; 2023 Feb; 29(2):91-99. PubMed ID: 36880490
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Validation of laboratory developed serology assays for detection of IgG antibody to severe acute respiratory syndrome coronavirus 2 in the South African population.
    Matefo L; Cloete VV; Armand BP; Dominique G; Samantha P; John F; Craig T; Daniel W; Theresa L; Sunetra G; Maréza B; Danelle VJ; Jane BF
    J Virol Methods; 2022 Sep; 307():114571. PubMed ID: 35750222
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.
    Peterhoff D; Glück V; Vogel M; Schuster P; Schütz A; Neubert P; Albert V; Frisch S; Kiessling M; Pervan P; Werner M; Ritter N; Babl L; Deichner M; Hanses F; Lubnow M; Müller T; Lunz D; Hitzenbichler F; Audebert F; Hähnel V; Offner R; Müller M; Schmid S; Burkhardt R; Glück T; Koller M; Niller HH; Graf B; Salzberger B; Wenzel JJ; Jantsch J; Gessner A; Schmidt B; Wagner R
    Infection; 2021 Feb; 49(1):75-82. PubMed ID: 32827125
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rapid and sensitive detection of immunoglobulin M (IgM) and IgG antibodies against canine distemper virus by a new recombinant nucleocapsid protein-based enzyme-linked immunosorbent assay.
    von Messling V; Harder TC; Moennig V; Rautenberg P; Nolte I; Haas L
    J Clin Microbiol; 1999 Apr; 37(4):1049-56. PubMed ID: 10074525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of SARS-CoV-2-specific antibodies via rapid diagnostic immunoassays in COVID-19 patients.
    Chansaenroj J; Yorsaeng R; Posuwan N; Puenpa J; Sudhinaraset N; Chirathaworn C; Poovorawan Y
    Virol J; 2021 Mar; 18(1):52. PubMed ID: 33750394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients.
    Cook AM; Faustini SE; Williams LJ; Cunningham AF; Drayson MT; Shields AM; Kay D; Taylor L; Plant T; Huissoon A; Wallis G; Beck S; Jossi SE; Perez-Toledo M; Newby ML; Allen JD; Crispin M; Harding S; Richter AG
    J Immunol Methods; 2021 Jul; 494():113046. PubMed ID: 33775672
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improved Detection Sensitivity of an Antigen Test for SARS-CoV-2 Nucleocapsid Proteins with Thio-NAD Cycling.
    Kyosei Y; Namba M; Yamura S; Watabe S; Yoshimura T; Sasaki T; Shioda T; Ito E
    Biol Pharm Bull; 2021 Sep; 44(9):1332-1336. PubMed ID: 34148926
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic Changes of Antibodies to SARS-CoV-2 in COVID-19 Patients at Early Stage of Outbreak.
    Shu H; Wang S; Ruan S; Wang Y; Zhang J; Yuan Y; Liu H; Wu Y; Li R; Pan S; Ouyang Y; Yuan S; Zhou P; Shang Y
    Virol Sin; 2020 Dec; 35(6):744-751. PubMed ID: 32720214
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serological assay for anti-SARS-CoV-2 antibodies improves sensitivity of diagnosis of COVID-19 patients.
    Rostamzadeh D; Mortezagholi S; Alinejad M; Jooya SR; Eskandarian M; Metvaei A; Vafaei S; Aboulghasemi H; Younesi V; Shabani M
    Med Microbiol Immunol; 2021 Dec; 210(5-6):283-289. PubMed ID: 34564742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19).
    Guo L; Ren L; Yang S; Xiao M; Chang D; Yang F; Dela Cruz CS; Wang Y; Wu C; Xiao Y; Zhang L; Han L; Dang S; Xu Y; Yang QW; Xu SY; Zhu HD; Xu YC; Jin Q; Sharma L; Wang L; Wang J
    Clin Infect Dis; 2020 Jul; 71(15):778-785. PubMed ID: 32198501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicenter evaluation of four immunoassays for the performance of early diagnosis of COVID-19 and assessment of antibody responses of patients with pneumonia in Taiwan.
    Lin YC; Lee YL; Cheng CY; Tseng WP; Wu JL; Lin CH; Chung MY; Kang CM; Lee YF; Chen CP; Huang CH; Liu CE; Cheng SH; Chen SC; Chen SY; Hsueh PR
    J Microbiol Immunol Infect; 2021 Oct; 54(5):816-829. PubMed ID: 33676864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of robust, indigenous ELISA for detection of IgG antibodies against CoV-2 N and S proteins: mass screening.
    Srivastava AK; Gupta A; Chauhan D; Meena RC; Sugadev R; Eslavath MR; Gupta H; Karuna ; Singh S; Singh Y; Tiwari RP; Kohli V; Varshney R; Ganju L
    Appl Microbiol Biotechnol; 2022 Sep; 106(18):6225-6238. PubMed ID: 35976427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
    Veyrenche N; Bolloré K; Pisoni A; Bedin AS; Mondain AM; Ducos J; Segondy M; Montes B; Pastor P; Morquin D; Makinson A; Le Moing V; Van de Perre P; Foulongne V; Tuaillon E
    J Med Virol; 2021 May; 93(5):3069-3076. PubMed ID: 33554363
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
    Djukic T; Mladenovic M; Stanic-Vucinic D; Radosavljevic J; Smiljanic K; Sabljic L; Devic M; Cujic D; Vasovic T; Simovic A; Radomirovic M; Cirkovic Velickovic T
    Virology; 2021 May; 557():15-22. PubMed ID: 33582454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma.
    Bundschuh C; Egger M; Wiesinger K; Gabriel C; Clodi M; Mueller T; Dieplinger B
    Clin Chim Acta; 2020 Oct; 509():79-82. PubMed ID: 32526218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of an immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Orientia tsutsugamushi infection.
    Jang WJ; Huh MS; Park KH; Choi MS; Kim IS
    Clin Diagn Lab Immunol; 2003 May; 10(3):394-8. PubMed ID: 12738637
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.